EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY 4.0

Correction to “Chidamide (a Histone Deacetylase Inhibitor) Plus Abiraterone in Metastatic Castration‐Resistant Prostate Cancer (mCRPC): A Phase Ib Trial”

MedComm · 2026-11 · 7 (11)

DOI: 10.1002/mco2.71023 ↗

Kurz gefasst

Korrektur in der Zeitschrift MedComm, online erschienen am 01.11.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to “Chidamide (a Histone Deacetylase Inhibitor) Plus Abiraterone in Metastatic Castration‐Resistant Prostate Cancer (mCRPC): A Phase Ib Trial”. MedComm, 7(11). https://doi.org/10.1002/mco2.71023

Vancouver

Correction to “Chidamide (a Histone Deacetylase Inhibitor) Plus Abiraterone in Metastatic Castration‐Resistant Prostate Cancer (mCRPC): A Phase Ib Trial”. MedComm. 2026;7(11). doi:10.1002/mco2.71023

BibTeX
@article{euvimed2026,
  title = {Correction to “Chidamide (a Histone Deacetylase Inhibitor) Plus Abiraterone in Metastatic Castration‐Resistant Prostate Cancer (mCRPC): A Phase Ib Trial”},
  journal = {MedComm},
  year = {2026},
  volume = {7},
  number = {11},
  doi = {10.1002/mco2.71023}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche